Introduction {#s0001}
============

During the last decades, the use of pesticides has increased dramatically, worldwide, in an effort to increase food production and control vector-borne diseases. Nevertheless, these agrochemicals have been claimed to be harmful to the environment and to the human health (Hou & Wu [@CIT0037]). Indeed, pesticides are released in large amounts in the environment, leading consequently to contamination of water, soil and air. Their residues have also been detected in food products prepared for human consumption (Cabras & Angioni [@CIT0016]). The World Health Organization (WHO) estimates that there are 3 million cases of pesticides poisoning in each year and up to 220,000 deaths. Moreover, epidemiological studies have stated a causal connection between human exposure to pesticides and a number of health outcomes including endocrine disrupting effects (Goetz et al. [@CIT0034]), mutagenicity (Bhinder & Chaudhry [@CIT0015]), neurotoxicity (Galal et al. [@CIT0032]), carcinogenicity (Greim et al. [@CIT0035]), hepatotoxicity (Ogutcu et al. [@CIT0053]), and nephrotoxicity (Hou et al. [@CIT0038]).

Among pesticides, penconazole \[1-(2-(2,4-dichlorophenyl)-pentyl)-1H-1,2,4-triazole\], a systemic triazole fungicide with preventive and curative properties, is widely and effectively used throughout the world for the prevention and control of powdery mildew disease in vineyards and other crops. This fungicide belongs to conazoles, a class of azole-based fungicides widely used in agriculture as well as in human and veterinary medicine applications for the treatment of local and systemic fungal infections. It acts by inhibiting a specific cytochrome P450, lanosterol-14α-demethylase (CYP51), which is required for ergosterol biosynthesis in order to maintain the proper membrane fluidity and permeability in fungi (Zarn et al. [@CIT0084]). Penconazole is classified by WHO as Class U to present, unlikely, an acute hazard in normal use. In a previous study, this fungicide has been shown to be toxic to the reproductive system of male rats (El-Sharkawy & El-Nisr [@CIT0030]). In addition, we have recently demonstrated that penconazole is a potent hepatotoxic and cardiotoxic (Chaâbane et al. [@CIT0018], [@CIT0019]) fungicide in rats. Furthermore, toxicological studies have shown an extensive oral absorption, a wide distribution in the body and an excretion of this fungicide predominately via urine, where numerous metabolites have been identified.

Since the kidney is the major organ for xenobiotics release, renal cells are thus exposed to high doses of metabolites, causing nephrotoxicity. So, kidney is considered as a sensitive organ against pesticides-induced toxicity and damage (Kalendar et al. [@CIT0040]). Indeed, various pesticides have been demonstrated to cause renal damage (Ahmed et al. [@CIT0004]; Shah & Iqbal [@CIT0070]; Ben Amara et al. [@CIT0013]). Oxidative stress and reactive oxygen species (ROS) production have been reported as the main mechanism of the nephrotoxicity (Shah & Iqbal [@CIT0070]). ROS, when produced in excess, could damage critical molecules such as lipids, proteins and nucleic acid bases, thereby resulting in cell cycle arrest and apoptosis (Perry et al. [@CIT0055]; Barnham et al. [@CIT0011]; Ting et al. [@CIT0073]).

To counteract oxidative stress, endogenous and exogenous antioxidants play a crucial role to remove ROS. They act as free radical scavengers preventing cells and tissue damage. Exogenous antioxidants obtained from natural sources are considered to be relatively safe and without undesirable side effects (Xavier et al. [@CIT0079]). Medicinal plants and herbs constitute a promising source of natural antioxidants. Many plant extracts are endowed with a variety of free radical scavenging molecules. Among them, phenolic compounds are well-known for their antioxidative activity, attributed mainly to their redox properties allowing them to act as the reducing agents, the hydrogen donors, the singlet oxygen quenchers as well as the metal chelators (Rice-Evans et al. [@CIT0063]).

*Nitraria retusa* (Forssk.) Asch. (Nitrariaceae), a native perennial species, is a salt-tolerant and drought-resistant shrub, which produces fleshy red fruits eaten by humans (Le Floc'h [@CIT0043]). A tasty refreshing juice may be extracted from the mature fruits. This plant is distributed in North Africa including Tunisia. Commonly known as 'Ghardaq', *N. retusa* is used in traditional medicine. The dry leaves serve as supplement to tea and used to make cataplasms. The ashes of this plant are applied on infected wounds in order to remove liquids (blood, lymph) and to facilitate the healing process (Shaltout et al. [@CIT0071]). We have previously shown that the aqueous extract obtained from *N. retusa* fruit can serve as a source of bioactive compounds such as polyphenols and flavonoids (Chaâbane et al. [@CIT0017]). We have also demonstrated that this extract exerts *in vitro* (Chaâbane et al. [@CIT0017]) as well as *in vivo* (Chaâbane et al. [@CIT0018]), a significant antioxidant activity. Nevertheless, the phenolic composition of *N. retusa* fruit has not been previously described.

To the best of our knowledge, no studies have examined the potential penconazole-induced nephrotoxicity. Therefore, the present study was conducted to assess some biochemical parameters, antioxidant status and histopathological alterations in the kidney of penconazole-exposed rats. We tried also to identify, for the first time, the phenolic compounds present in the aqueous extract of *N. retusa* fruit and to determine whether the treatment with this extract could alleviate penconazole-induced nephrotoxicity.

Materials and methods {#s0002}
=====================

Chemicals {#s0003}
---------

Penconazole is a triazole fungicide (C~13~H~15~Cl~2~N~3~). The commercial formulation studied in the present work was Topas^®^, which contained 100 g/L of penconazole, the active ingredient, and was produced by Syngenta Company (Bâle, Suisse). Glutathione (GSH), 5,5′-dithiobis-2-nitrobenzoic acid (DTNB), thiobarbituric acid, 1,1,3,3-tetrathoxypropane (TEP), 2,4-dinitrophenylhydrazine (DNPH) and nitro blue tetrazolium (NBT) were purchased from Sigma Chemical Co. (St. Louis, MO). The other ones of analytical grade were purchased from standard commercial suppliers.

Plant material {#s0004}
--------------

Fresh ripe fruits of *N. retusa* were collected from Kerkennah Island (Sfax, Tunisia). The plant was identified in botanic laboratory (Faculty of Sciences, University of Sfax, Tunisia), according to the Flora of Tunisia (Pottier-Alapetite [@CIT0060]).

Mineral composition of *N. retusa* fruit {#s0005}
----------------------------------------

The content of magnesium (Mg^2+^), sodium (Na^+^), calcium (Ca^2+^), zinc (Zn^2+^), iron (Fe^2+^) and copper (Cu^2+^) in *N. retusa* fruit was determined by atomic absorption spectrometry (Sherwood 410) after digestion with concentrated nitric acid (AOAC [@CIT0008]). Briefly, after being separated from the seeds, the fruit pulps of *N. retusa* were homogenized in a domestic blender (Ufesa Supplier, Spain). An amount of 1 g of the homogenate was dried at 105 °C for 24 h and subsequently incinerated in a muffle furnace at 550 °C for 4 h. The residue of incineration was cooled, dissolved in 1 mL of concentrated nitric acid and allowed to stand for 30 min. After that, the sample was diluted with 10 mL of deionized water and filtered with Whatman No.1 filter paper. Then, the solution was transferred to a volumetric flask and diluted to a final volume of 25 mL with deionized water. The resulting extract was used for mineral content determination. Results were expressed as mg/100 g *N. retusa* fresh weight (NRFW).

Preparation of *N. retusa* fruit aqueous extract {#s0006}
------------------------------------------------

An aqueous extract of *N. retusa* fruit was prepared following the procedure of Benvenuti et al. ([@CIT0014]), with slight modifications. Briefly, 200 g of the previously prepared fruit homogenate were extracted with 200 mL distilled water under continuous stirring for 60 min. The extract was filtered under vacuum through Whatman No.1 filter paper on a Buchner funnel, and the residue was extracted again by the same way. The obtained filtrates were combined, lyophilized and kept in the dark at 4 °C until use.

High-pressure liquid chromatography--high resolution mass spectrometry (HPLC-HRMS) analysis {#s0007}
-------------------------------------------------------------------------------------------

The phenolic compounds present in the aqueous extract of *N. retusa* fruit were analyzed using ultra high-pressure liquid chromatography (UPLC 1290 Infinity) coupled with high resolution--mass spectrometry (HR-MS Q-TOF UHD 6538) from Agilent Technologies. In brief, chromatographic separation was carried out using a Thermo Hypersyl Gold column (4.6 × 150 × 5 μm) at a flow rate of 0.7 mL/min. The separation gradient was generated using 0.1% formic acid in water (solvent A), and acetonitrile (solvent B). The gradient was defined as follows: from 0 to 20 min, 6% B; from 20 to 35 min, 18% B; from 35 to 45 min, 28% B; from 45 to 48 min, 60% B; from 48 to 55 min, 90% B. Cleaning of the column was achieved with 90% B for 5 min. The mass spectra were acquired using a dual ESI ionization in positive-ion mode. The nebulization gas and the ion spray voltage were adjusted to 30 psi and 3.5 kV, respectively. The temperature of the ion source was fixed to 300 °C. All data were acquired and processed using Mass Hunter B.05.01 software. The identification was performed according to a home-generated database containing 500 compounds and a mixture of standards containing 30 phenolic compounds, as described by Koubaa et al. ([@CIT0042]).

Animals and treatment {#s0008}
---------------------

A total of 24 male Wistar rats (251 ± 3 g) were purchased from the Central Pharmacy (SIPHAT, Tunisia). The rats were housed under standard laboratory conditions of temperature (22 ± 2 °C), relative humidity (40%) and 12 h light/dark cycles. They were fed with standard pellet diet (SNA, Sfax, Tunisia) and given drinking water *ad libitum*. Approval for rat experiments was obtained from the ethical Committee at Sciences Faculty of Sfax with ethics approval number 1204 and all the experimental procedures were in accordance with the International Guidelines for Animal Care (Council of European Communities [@CIT0021]). The animals were randomly divided into four groups of six each as follows:Group 1 (Controls): rats received distilled water.Group 2 (PEN): no treatment was performed during the first 6 days, then rats received intraperitoneally 67 mg/kg body weight (1/30 LD50) of penconazole every 2 days from day 7 until day 15, the sacrifice day.Group 3 (NRE + PEN): received daily by gavage during the first six days 300 mg/kg body weight of lyophilized *N. retusa* extract (corresponding, for each rat weighing a mean value of 251 g, to 75 mg of lyophilized *N. retusa* extract dissolved in 1 mL of distilled water). From day 7 until day 15, rats received aqueous extract of *N. retusa* fruit (300 mg/kg body weight) daily by gavage and penconazole (67 mg/kg body weight) every 2 days by intraperitoneal way.Group 4 (NRE): serving as positive controls, received daily by gavage *N. retusa* aqueous extract (300 mg/kg body weight) for 15 days.

The dose of penconazole used in the present work was selected on the basis of the previous study carried out by El-Sharkawy and El-Nisr ([@CIT0030]). These authors have used two doses of penconazole, 50 mg/kg body weight and 100 mg/kg body weight (representing, respectively, 1/40 and 1/20 of LD~50~), which induce structural and functional testicular impairment in adult male rats. For our experiment, we have chosen an intermediate dose (67 mg/kg body weight), which represented 1/30 LD~50~ and caused toxicity without lethality. Indeed, a dose higher than 67 mg/kg body weight provoked haemorrhage and diarrhoea. Concerning *N. retusa* extract, a preliminary dose-response study showed that a dose higher than 300 mg/kg body weight was found to cause diarrhoea in exposed rats, which could be due to the presence of fibres in *N. retusa* fruits as reported by Hegazy et al. ([@CIT0036]).

Twenty four hours before the sacrifice day, the rats were placed individually in metabolic cages for urine collection. After recording 24 h urine volumes, samples were centrifuged at 5000 *g* for 5 min to eliminate the probable presence of excrements. The supernatants were collected and then stored at −20 °C for further analysis. At the end of the experiment and after 15 days of treatment, the rats were sacrificed by cervical dislocation to avoid stress condition. Blood samples were collected into heparin-coated tubes and centrifuged at 2200 *g* for 10 min. Plasma samples were drawn and stored at −20 °C until analysis. Kidney tissues were dissected out, cleaned from adipose tissue and weighed. Some samples were rinsed, homogenized in Tris-HCl buffer (pH 7.4) and centrifuged. The resulting supernatants were collected and kept at −80 °C until biochemical analysis. Other samples were fixed in 10% buffered formalin solution and embedded in paraffin for histological examination. For the biochemical and the histological experiments, samples (kidney tissue, plasma, urine) were taken from six rats in each group.

Biochemical assays {#s0009}
------------------

### Protein quantification in kidneys {#s0010}

Kidney protein content was determined by Lowry et al. ([@CIT0046]) method using bovine serum albumin as standard.

### Estimation of urea, uric acid, creatinine and creatinine clearance {#s0011}

The levels of urea, uric acid and creatinine in plasma and urine were assayed spectrophotometrically using commercially available diagnostic kits (Biomaghreb, Tunisia, Ref. 20143, 20095, 20151, respectively). Creatinine clearance was calculated using *UV*/*P* equation (Charrel [@CIT0020]), where *U* is the urinary creatinine level, *V* the urinary volume collected within 24 h and *P* the plasma creatinine level.

### Kidney and plasma lactate dehydrogenase activities {#s0012}

Lactate dehydrogenase (LDH) activities in the kidney and plasma were measured using a commercially available diagnostic kit (Biomaghreb, Tunisia, Ref. 200125).

### Plasma alkaline phosphatase and gamma glutamyltranspeptidase activities {#s0013}

Plasma alkaline phosphatase (ALP) and gamma glutamyltranspeptidase (GGT) activities were determined using diagnostic kits (Biomaghreb, Tunisia, Ref. 20015 and 20022, respectively).

### Evaluation of kidney lipid peroxidation {#s0014}

The concentrations of malondialdehyde (MDA), an index of lipid peroxidation, in kidney tissue were determined according to the method by Draper and Hadley ([@CIT0025]). The MDA values were calculated using TEP as standard and expressed as nmol of MDA/g tissue.

### Estimation of hydrogen peroxide generation {#s0015}

Hydrogen peroxide (H~2~O~2~) generation in kidney tissue was assessed by Ou and Wolff method (Ou & Wolff [@CIT0054]). The amount of H~2~O~2~ in the sample was determined using the extinction coefficient of 2.67 × 10^5^ cm^−1^ M^−1^ and results were expressed as nmol/mg protein.

### Determination of protein carbonyl levels in kidney {#s0016}

Protein carbonyl (PCO) content in kidney tissue was measured using the DNPH method by Reznick and Packer ([@CIT0062]). Results were expressed as nmol/mg protein.

### Determination of advanced oxidation protein product levels in kidney {#s0017}

The kidney levels of advanced oxidation protein products (AOPP) were determined according to the method of Kayali et al. ([@CIT0041]), using the extinction coefficient of 261 cm^−1 ^mM^−1^. Results were expressed as nmol/mg protein.

### Determination of antioxidant enzyme activities {#s0018}

The catalase (CAT) activity was assayed as described by Aebi ([@CIT0003]) using H~2~O~2~ as substrate. The decrease in absorbance due to H~2~O~2~ degradation was recorded at 240 nm and CAT activity was calculated in terms of μmol H~2~O~2~ consumed/min/mg of protein.

The superoxide dismutase (SOD) activity was determined by monitoring the photochemical reduction of NBT according to the method of Beauchamp and Fridovich ([@CIT0012]). One unit of SOD activity corresponded to the amount of enzyme required to cause 50% inhibition of NBT reduction at 560 nm. SOD activity was expressed as units/mg protein.

The glutathione peroxidase (GPx) activity was estimated according to the method of Flohe and Gunzler ([@CIT0031]). The enzyme activity was expressed as nmol of GSH oxidized/min/mg protein.

### Determination of non-protein thiol levels {#s0019}

Kidney non-protein thiol (NPSH) levels were determined by the method by Ellman ([@CIT0029]) and the results were expressed as μmol/g tissue.

### Determination of GSH levels {#s0020}

The GSH content in kidney tissue was assayed according to the method by Ellman ([@CIT0029]) modified by Jollow et al. ([@CIT0039]). Results were expressed as μg/g tissue.

### Determination of metallothionein content {#s0021}

The concentration of metallothionein (MT) in kidney tissue was estimated according to the method by Viarengo et al. ([@CIT0075]) modified by Petrovic et al. ([@CIT0056]). Results were expressed as μmol GSH/g tissue.

Histological studies {#s0022}
--------------------

For histological examination, some kidneys were removed from control and treated rats. They were fixed in 10% buffered formalin solution and then embedded in paraffin. Sections of 5 μm thickness were placed on slides and stained with haematoxylin and eosin for histological evaluation under light microscopy. Six slides were prepared from each kidney tissue. All sections were evaluated for the degree of tubular and glomerular injury. Each kidney slide was examined and assigned for severity of changes using scores on a scale of none (−), mild (+), moderate (++) and severe (+++) damage.

Statistical analysis {#s0023}
--------------------

The data were analyzed using the statistical package program Stat view 5 Software for Windows (SAS Institute, Berkley, CA). Statistical analysis was performed using one-way analysis of variance (ANOVA) followed by Fisher protected least significant difference (PLSD) test as a *post hoc* test for comparison between groups. Student unpaired *t* test, used for comparison between two groups, was also required. All values were expressed as means ± SD. Differences were considered significant if *p* \< 0.05.

Results {#s0024}
=======

*In vitro* study {#s0025}
----------------

### Mineral analysis of *N. retusa* fruit {#s0026}

The mineral content of *N. retusa* fruit was determined in the present study ([Table 1](#t0001){ref-type="table"}). The most abundant macro-element was Na^+ ^(410.82 mg/100 g NRFW) while Ca^2+ ^and Mg^2+ ^were found in smaller amounts than Na^+ ^(101.82 and 54.69 mg/100 g NRFW, respectively). Regarding the microelements, the highest value was represented by Fe^2+ ^(6.78 mg/100 g NRFW), followed by Zn^2+ ^(0.48 mg/100 g NRFW) and Cu^2+ ^(0.322 mg/100 g NRFW).

###### 

Mineral content of *N. retusa* fruit.

  Minerals   Concentration (mg/100 g*N. retusa* fresh weight)
  ---------- --------------------------------------------------
  Mg^2+^     54.69
  Na^+^      410.82
  Ca^2+^     101.82
  Zn^2+^     0.48
  Fe^2+^     6.78
  Cu^2+^     0.322

Mg^2+^: magnesium, Na^+^: sodium, Ca^2+^: calcium, Zn^2+^: zinc, Fe^2+^: iron, Cu^2+^: copper.

### Polyphenols identification {#s0027}

The phenolic compounds profile of *N. retusa* fruit aqueous extract is shown in [Figure 1](#F0001){ref-type="fig"}. Based on analysis by HPLC-HRMS, the major identified components were hydroxycaffeic acid **(1)**, 3-*O*-methylgallic acid **(2)**, *p*-coumaric acid **(3)**, 3′-*O*-methyl-(-)-epicatechin 7-*O*-glucuronide **(4)**, 4′-*O*-methyl-(-)-epicatechin 3′-*O*-glucuronide **(5)**, epicatechin 3′-*O*-glucuronide **(6)**, taxifoline **(7)**, kaempferol **(8)**, cyanidin 3-*O*-rutinoside **(9)**, chlorogenic acid **(10)** and kaempferol 3-glucoside **(11)**.

![HPLC--HRMS chromatogram representing the polyphenols extracted from the aqueous extract of *N. retusa* fruit and chemical structure of the major components identified \[hydroxycaffeic acid (**1**), 3-*O*-methylgallic acid (**2**), *p*-coumaric acid (**3**), 3′-*O*-methyl-(-)-epicatechin 7-*O*-glucuronide (**4**), 4′-*O*-methyl-(-)-epicatechin 3′-*O*-glucuronide (**5**), epicatechin 3′-*O*-glucuronide (**6**), taxifoline (**7**), kaempferol (**8**), cyanidin 3-*O*-rutinoside (**9**), chlorogenic acid (**10**) and kaempferol 3-glucoside (**11**)\]. The identification was performed according to a home-generated database containing 500 compounds and a mixture of standards containing 30 phenolic compounds.](IPHB_A_1278455_F0001_C){#F0001}

*In vivo* study {#s0028}
---------------

### Body, absolute and relative kidney weights. Food and water intakes {#s0029}

During the experimental period, there was no observed mortality in any experimental group. Moreover body, absolute and relative kidney weights as well as the daily food intake of treated animals were similar to those of controls. While a significant increase (+30%) in the daily water consumption was shown in penconazole-treated rats, as compared to the controls ([Table 2](#t0002){ref-type="table"}).

###### 

Body, absolute and relative kidney weights. Food and water intake of control and treated rats with penconazole (PEN), *N. retusa* aqueous extract (NRE), or their combination (NRE + PEN).

  Parameters and treatments            Controls        PEN                                               NRE + PEN                                           NRE
  ------------------------------------ --------------- ------------------------------------------------- --------------------------------------------------- ---------------
  Initial body weight (g)              248.67 ± 8.48   249.67 ± 5.61                                     251.67 ± 4.27                                       254.17 ± 6.43
  Final body weight (g)                261.00 ± 6.81   264.33 ± 5.20                                     262.00 ± 4.86                                       267.67 ± 9.18
  Absolute kidney weight (g)           1.61 ± 0.15     1.68 ± 0.10                                       1.61 ± 0.06                                         1.76 ± 0.17
  Relative kidney weight (g/100g bw)   0.62 ± 0.05     0.63 ± 0.03                                       0.61 ± 0.02                                         0.66 ± 0.05
  Food intake (g/day/rat)              16.68 ± 1.59    16.08 ± 1.77                                      15.89 ± 1.55                                        16.39 ± 1.42
  Water intake (mL/day/rat)            25.47 ± 2.45    33.16 ± 2.64[\*\*\*](#TF6){ref-type="table-fn"}   26.07 ± 2.22[^\#\#\#^](#TF8){ref-type="table-fn"}   26.03 ± 1.64

Values are means ± SD for six rats in each group.

bw: body weight.

PEN group vs. control group:

*p* \< 0.001.

NRE + PEN group vs PEN group:

*p* \< 0.001.

### Biomarkers of renal toxicity {#s0030}

Results showed that creatinine, urea and uric acid levels of penconazole-treated rats were higher in plasma (+20, +61 and +65%, respectively) and lower in urine (−71, −66 and −47%) than those of the controls ([Table 3](#t0003){ref-type="table"}). These observations were associated with a significant elevation of 24 h urinary volume and a reduction in creatinine clearance ([Table 3](#t0003){ref-type="table"}). Treatment of penconazole-treated rats with *N. retusa* extract improved the levels of renal biomarkers, compared to those of PEN group.

###### 

Urinary volume, creatinine clearance, plasma and urinary levels of creatinine, urea and uric acid, and BUN of control and treated rats with penconazole (PEN), *N. retusa* aqueous extract (NRE) or their combination (NRE + PEN).

  Parameters and treatments                       Controls           PEN                                                    NRE + PEN                                                                                  NRE
  ----------------------------------------------- ------------------ ------------------------------------------------------ ------------------------------------------------------------------------------------------ ---------------------------------------------------
  Urinary volume (mL/24 h)                        5.33 ± 0.41        14.00 ± 1.87[\*\*\*](#TF16){ref-type="table-fn"}       11.67 ± 0.41[\*\*\*](#TF16){ref-type="table-fn"}[\#\#](#TF19){ref-type="table-fn"}         7.67 ± 1.08[\*\*\*](#TF16){ref-type="table-fn"}
  Creatinine clearance (μL/min)                   536.75 ± 81.31     339.58 ± 39.50[\*\*\*](#TF16){ref-type="table-fn"}     533.28 ± 88.10[\#\#\#](#TF20){ref-type="table-fn"}                                         640.26 ± 83.20[\*](#TF14){ref-type="table-fn"}
  Creatinine (μmol/L)                                                                                                                                                                                                   
   Plasma                                         52.40 ± 3.12       62.62 ± 6.12[\*\*](#TF15){ref-type="table-fn"}         54.67 ± 4.86[\#](#TF18){ref-type="table-fn"}                                               54.34 ± 0.96
   Urine                                          7551.25 ± 573.05   2216.67 ± 440.08[\*\*\*](#TF16){ref-type="table-fn"}   3580.63 ± 526.25[\*\*\*](#TF16){ref-type="table-fn"}[\#\#\#](#TF20){ref-type="table-fn"}   6550.00 ± 39.53[\*\*](#TF15){ref-type="table-fn"}
  Urea (mmol/L)                                                                                                                                                                                                         
   Plasma                                         5.82 ± 0.39        9.35 ± 0.48[\*\*\*](#TF16){ref-type="table-fn"}        7.38 ± 0.25[\*\*\*](#TF16){ref-type="table-fn"}[\#\#\#](#TF20){ref-type="table-fn"}        6.49 ± 0.23[\*\*](#TF15){ref-type="table-fn"}
   Urine                                          472.61 ± 66.84     161.22 ± 9.60[\*\*\*](#TF16){ref-type="table-fn"}      234.16 ± 31.28[\*\*\*](#TF16){ref-type="table-fn"}[\#\#\#](#TF20){ref-type="table-fn"}     359.57 ± 19.09[\*\*](#TF15){ref-type="table-fn"}
  Uric acid (μmol/L)                                                                                                                                                                                                    
   Plasma                                         73.13 ± 6.04       120.71 ± 9.60[\*\*\*](#TF16){ref-type="table-fn"}      64.53 ± 5.30[\*\*\*](#TF16){ref-type="table-fn"}[\#](#TF18){ref-type="table-fn"}           76.93 ± 3.70
   Urine                                          247.50 ± 39.47     131.67 ± 14.72[\*\*\*](#TF16){ref-type="table-fn"}     147.5 ± 7.58[\*\*\*](#TF16){ref-type="table-fn"}[\#](#TF18){ref-type="table-fn"}           215.00 ± 30.17
  BUN[^a^](#TF11){ref-type="table-fn"} (mmol/L)   2.72 ± 0.18        4.37 ± 0.22[\*\*\*](#TF16){ref-type="table-fn"}        3.45 ± 0.12[\*\*\*](#TF16){ref-type="table-fn"}[\#\#\#](#TF20){ref-type="table-fn"}        3.06 ± 0.11[\*\*](#TF15){ref-type="table-fn"}

Values are means ± SD for six rats in each group.

BUN: blood urea nitrogen.

BUN was calculated using the formula conversion:

BUN (mmol/L) = \[urea(mmol/L)\]/2.14.

PEN, NRE + PEN and NRE groups vs. control group:

*p* \< 0.05.

*p* \< 0.01.

*p* \< 0.001.

NRE + PEN group vs PEN group:

*p* \< 0.05.

*p* \< 0.01.

*p* \< 0.001.

### Plasma ALP, GGT and LDH activities and kidney LDH activity {#s0031}

In penconazole-treated rats, plasma ALP and GGT activities decreased by 22 and 35%, respectively, when compared to controls ([Table 4](#t0004){ref-type="table"}). In addition, LDH activity increased by 57% in the plasma while it decreased by 22% in the kidney of penconazole-treated rats, when compared to the controls ([Table 4](#t0004){ref-type="table"}). Administration of *N. retusa* extract increased the activities of ALP and GGT by 8 and 28%, respectively, as compared to penconazole-treated rats. Moreover, in NRE + PEN group, LDH activity decreased by 30% in the plasma and increased by 13% in the kidney, as compared to PEN group ([Table 4](#t0004){ref-type="table"}).

###### 

Plasma ALP, GGT and LDH activities and kidney LDH activity in control and treated rats with penconazole (PEN), *N. retusa* aqueous extract (NRE) or their combination (NRE + PEN).

  Parameters and treatments   Controls          PEN                                                   NRE + PEN                                                                             NRE
  --------------------------- ----------------- ----------------------------------------------------- ------------------------------------------------------------------------------------- ---------------------------------------------------
  Plasma                                                                                                                                                                                     
   ALP (IU/L)                 122.5 ± 13.65     95.42 ± 5.94[\*\*](#TF25){ref-type="table-fn"}        103.08 ± 5.60[\*\*](#TF25){ref-type="table-fn"}                                       112.67 ± 5.49
   GGT (IU/L)                 11.50 ± 1.75      7.44 ± 0.50[\*\*\*](#TF26){ref-type="table-fn"}       9.52 ± 0.84[\*](#TF24){ref-type="table-fn"}[\#\#\#](#TF29){ref-type="table-fn"}       12.30 ± 2.43
   LDH (IU/L)                 1162.33 ± 97.84   1824.17 ± 94.96[\*\*\*](#TF26){ref-type="table-fn"}   1274.67 ± 89.08[\*](#TF24){ref-type="table-fn"}[\#\#\#](#TF29){ref-type="table-fn"}   1312.00 ± 21.43[\*\*](#TF25){ref-type="table-fn"}
  Kidney                                                                                                                                                                                     
   LDH (IU/L)                 3.37 ± 0.29       2.63 ± 0.23[\*\*\*](#TF26){ref-type="table-fn"}       2.97 ± 0.29[\*](#TF24){ref-type="table-fn"}[\#](#TF28){ref-type="table-fn"}           3.27 ± 0.22

Values are means ± SD for six rats in each group.

ALP: alkaline phosphatase, GGT: gamma glutamyltranspeptidase, LDH: Lactate dehydrogenase.

PEN, NRE + PEN and NRE groups vs. control group:

*p* \< 0.05.

*p* \< 0.01.

*p* \< 0.001.

NRE + PEN group vs PEN group:

*p* \< 0.05.

*p* \< 0.001.

### Lipid peroxidation in the kidney {#s0032}

Our results revealed an increase of lipid peroxidation in the kidney of penconazole-treated rats as evidenced by the enhanced MDA level (+67%) when compared to controls. In NRE + PEN group, the MDA level was significantly reduced (−10%) compared to the PEN group ([Table 5](#t0005){ref-type="table"}).

###### 

Kidney MDA, H~2~O~2~, PCO, AOPP, NPSH, GSH and MT levels in control and treated rats with penconazole (PEN), *N. retusa* aqueous extract (NRE) or their combination (NRE + PEN).

  Parameters and treatments    Controls        PEN                                                  NRE + PEN                                                                             NRE
  ---------------------------- --------------- ---------------------------------------------------- ------------------------------------------------------------------------------------- ----------------
  MDA (nmol/g tissue)          142.75 ± 9.63   238.01 ± 18.62[\*\*\*](#TF35){ref-type="table-fn"}   213.81 ± 15.14[\*\*\*](#TF35){ref-type="table-fn"}[\#](#TF37){ref-type="table-fn"}    147.22 ± 16.49
  H~2~O~2~ (nmol/mg protein)   0.042 ± 0.004   0.064 ± 0.005[\*\*\*](#TF35){ref-type="table-fn"}    0.056 ± 0.005[\*\*\*](#TF35){ref-type="table-fn"}[\#](#TF37){ref-type="table-fn"}     0.045 ± 0.004
  PCO (nmol/mg protein)        0.59 ± 0.05     0.84 ± 0.05[\*\*\*](#TF35){ref-type="table-fn"}      0.75 ± 0.06[\*\*\*](#TF35){ref-type="table-fn"}[\#](#TF37){ref-type="table-fn"}       0.56 ± 0.05
  AOPP (nmol/mg protein)       0.20 ± 0.02     0.37 ± 0.02[\*\*\*](#TF35){ref-type="table-fn"}      0.31 ± 0.01[\*\*\*](#TF35){ref-type="table-fn"}[\#\#\#](#TF38){ref-type="table-fn"}   0.21 ± 0.02
  NPSH (μmol/g tissue)         2.40 ± 0.12     2.76 ± 0.05[\*\*\*](#TF35){ref-type="table-fn"}      2.50 ± 0.04[\*](#TF33){ref-type="table-fn"}[\#\#\#](#TF38){ref-type="table-fn"}       2.47 ± 0.07
  GSH (μg/g tissue)            29.74 ± 1.45    34.05 ± 2.30[\*\*](#TF34){ref-type="table-fn"}       31.55 ± 1.08[\*](#TF33){ref-type="table-fn"}[\#](#TF37){ref-type="table-fn"}          30.86 ± 0.71
  MT (μmol GSH/g tissue)       0.49 ± 0.01     0.57 ± 0.06[\*\*](#TF34){ref-type="table-fn"}        0.50 ± 0.03[\#](#TF37){ref-type="table-fn"}                                           0.47 ± 0.04

Values are means ± SD for six rats in each group.

MDA: malondialdehyde, H~2~O~2~: hydrogen peroxide, PCO: protein carbonyls, AOPP: advanced oxidation protein products, NPSH: non-protein thiols, GSH: reduced glutathione MT: metallothionein.

PEN and NRE + PEN groups vs. control group:

*p* \< 0.05.

*p* \< 0.01.

*p* \< 0.001.

NRE + PEN group vs PEN group:

*p* \< 0.05.

*p* \< 0.001.

### Hydrogen peroxide generation in the kidney {#s0033}

The level of H~2~O~2~ generated in kidney was significantly increased (+52%) in the PEN group when compared to controls. Administration of *N. retusa* extract to penconazole-treated rats decreased significantly (−12%) H~2~O~2~ level as compared to the PEN group.

### Protein oxidative markers in the kidney {#s0034}

In the PEN group, a significant increase of PCO and AOPP levels in the kidney tissue of adult rats (+42 and +85%, respectively) was observed when compared to the controls. Treatment with *N. retusa* extract resulted in a marked decrease of kidney PCO and AOPP levels (−11 and −16%, respectively) when compared to the Pen group ([Table 5](#t0005){ref-type="table"}).

### Non-enzymatic antioxidant status in the kidney {#s0035}

The levels of non-enzymatic antioxidants such as NPSH, GSH and MT were determined in the kidney of experimental animals. Results showed that penconazole treatment increased significantly the levels of NPSH (+15%), GSH (+16%) and MT (+16%), as compared to controls ([Table 5](#t0005){ref-type="table"}). These modifications were alleviated following administration of *N. retusa* extract to penconazole treated rats as indicated by the significant decrease of NPSH (−9%), GSH (−7%) and MT (−12%) levels compared to those of PEN group.

### Enzymatic antioxidant status in the kidney {#s0036}

Penconazole treatment resulted in a significant increase of CAT (+26%), SOD (+25%) and GPx activities (+23%) when compared to controls. Treatment with *N. retusa* aqueous extract reduced significantly the activities of these enzymes by 8, 13 and 14%, respectively, compared to those of penconazole-treated group. Treatment of adult rats with *N. retusa* extract alone produced no changes in the activities of these enzymes, when compared to those of negative controls ([Figure 2](#F0002){ref-type="fig"}).

![Antioxidant enzyme activities (A) CAT, (B) SOD and (C) GPx in kidney of control and treated rats with penconazole (PEN), *N. retusa* aqueous extract along with penconazole (NRE + PEN) and *N. retusa* aqueous extract (NRE). Values are means ± SD for six rats in each group. PEN and NRE + PEN groups vs control group: \**p* \< 0.05; \*\**p* \< 0.01; \*\*\**p* \< 0.001. NRE + PEN group vs PEN group: \#*p* \< 0.05; \#\#*p* \< 0.01; \#\#\#*p* \< 0.001](IPHB_A_1278455_F0002_C){#F0002}

### Kidney histoarchitecture {#s0037}

Histological studies showed that control rats presented a normal kidney histoarchitecture with normal tubules and intact glomeruli ([Figure 3(A)](#F0003){ref-type="fig"}). While kidney histology of the PEN group revealed several abnormalities, detected both in the tubules and in glomeruli, when compared to the controls. In fact, penconazole treatment caused necrosis of the epithelial cells lining the tubules ([Figure 3(B1,B3)](#F0003){ref-type="fig"}), in addition to the infiltration of inflammatory leucocytes ([Figure 3(B2)](#F0003){ref-type="fig"}). Glomeruli fragmentation and Bowman's space enlargement were also observed in the kidney of penconazole-treated rats ([Figure 3(B1,B2)](#F0003){ref-type="fig"}). The co-administration of *N. retusa* extract to penconazole-treated rats reduced markedly the glomeruli fragmentation and the Bowman's space enlargement when compared to the PEN group ([Figure 3(C)](#F0003){ref-type="fig"}). Furthermore, this extract attenuated the infiltration of inflammatory leucocytes and the damages to the epithelial cells lining the tubules induced by penconazole ([Figure 3(C)](#F0003){ref-type="fig"}). Microscopic examination of kidney sections of NRE group showed normal histological structure of renal tubules and glomeruli ([Figure 3(D)](#F0003){ref-type="fig"}). The histological changes in treated rats were graded and summarized in [Table 6](#t0006){ref-type="table"}.

![Histological kidney sections of (A) control and (B1, B2 and B3) treated rats with penconazole, (C) *N. retusa* aqueous extract along with penconazole and (D) *N. retusa* aqueous extract. Optic microscopy: H&E (400×). Arrows indicate: Glomeruli fragmentation, necrosis of the epithelial cells lining the tubules, Bowman's space enlargement, inflammatory leucocytes infiltration](IPHB_A_1278455_F0003_C){#F0003}

###### 

Grading of the histopathological changes in the kidney sections.

  Groups      Enlarged Bowman'sspace   Glomerulifragmentation   Necrosis of the epithelial cellslining the tubules   Infiltration ofleucocytes
  ----------- ------------------------ ------------------------ ---------------------------------------------------- ---------------------------
  Controls    −                        −                        −                                                    −
  PEN         ++                       +++                      +++                                                  +++
  NRE + PEN   −                        −                        \+                                                   −
  NRE         −                        −                        −                                                    −

Scoring was done as follows: none (−), mild (+), moderate (++) and severe (+++).

Discussion {#s0038}
==========

In recent years, there is a growing concern worldwide over the indiscriminate use of pesticides, resulting in environmental pollution and toxicity risk to non-target organisms. Indeed, pesticides exposure has been associated with free radical-mediated damage in biological systems (Banerjee et al. [@CIT0010]). This has prompted the intensive efforts to search for new antioxidant compounds, especially from natural sources, which are considered to be relatively safe and without side effects. Medicinal plants have been largely used in traditional medicine as remedies for many kinds of human diseases. The present study was undertaken to evaluate the potential toxic effects of penconazole on the kidney of adult rats and to investigate the possible protective effect of *N. retusa* fruit aqueous extract against toxicity induced by this fungicide.

In the present work, penconazole treatment had no effect on body weight as well as on food intake of adult rats, suggesting that this fungicide did not probably affect their appetite. Absolute and relative kidney weights were also unaffected following penconazole exposure. While, a significant rise in water consumption was recorded for penconazole-treated rats, which could be explained as a mechanism to counteract the toxicity induced by this fungicide.

Although there were no morphological changes including body or kidney weights in penconazole-treated rats, exposure to this fungicide caused alteration of renal function. Indeed, creatinine, creatinine clearance, urea and blood urea nitrogen (BUN) are used as indicators of renal function. Our results showed an increase of plasma levels in creatinine, urea, BUN and a reduced creatinine clearance in penconazole-treated rats, indicating renal dysfunction with a reduction in glomerular filtration rate. Increased plasma creatinine and BUN levels have been recorded by Takaori ([@CIT0072]) in rats fed with thiophanate-methyl, a benzimidazole fungicide, and by Badgujar et al. ([@CIT0009]) in rats exposed to fipronil, a phenyl pyrazole insecticide. This impairment in glomerular filtration rate was accompanied by an increase in 24-h urine volume, which might happen as a consequence of a reduced water reabsorption capacity by tubular epithelial cells.

Uric acid was another parameter used in the present work to assess kidney function. It is known for its antioxidant capacity based on its ability to scavenge free radicals (Alvarez-Lario & Macarron-Vicente [@CIT0005]). An increase of plasma uric acid level after exposure to penconazole might reflect body response to an excess of ROS production, since uric acid is a potent free radicals scavenger. This finding is in agreement with the previous study of El-Demerdash et al. ([@CIT0028]) where plasma uric acid was found to be increased in the kidney of rats exposed to methomyl, a carbamate pesticide.

Administration of *N. retusa* aqueous extract to penconazole-treated rats attenuated the kidney impairment as suggested by a significant amelioration of the renal biomarkers indicated earlier. Nevertheless, we have noted a significant increase of urinary volume in rats receiving *N. retusa* aqueous extract alone, as compared to control rats. Our data indicated that this wild medicinal plant exerted probably a diuretic activity which could be due to its high salt content, as reported by us. In fact, *N. retusa* fruit contained high amounts of Na^+^,^ ^which could be due to its halophyte nature. Besides, according to Hegazy et al. ([@CIT0036]), this species fruit is rich in potassium (263.33 ± 6.11 mg/100 g NRFW), which is reported to have a diuretic effect (Nelson & Cox [@CIT0052]). In addition, the presence of flavonoids in *N. retusa* fruit (Chaâbane et al. [@CIT0017]) could explain the increase of diuresis as reported by Yuliana et al. ([@CIT0082]) who have indicated that flavonoids cause polyuria. Similar results have been found by Durairaj et al. ([@CIT0026]) concerning the effects of *Oxystelma esculentum* R. Br. (*Asclepiadaceae*) methanolic extract on diuresis in rats. Treatment of rats with *N. retusa* fruit aqueous extract induced also a significant rise in plasma urea and BUN values, which could be ascribed to the dehydratation caused by the diuretic effect of this extract, as indicated by Nayeem and Quadri ([@CIT0051]) in albino mice administered with *Boswellia serrata* Roxb. (*Burseraceae*) leaf extract.

As described previously, kidney function impairment could be attributed to oxidative damage probably caused by penconazole. It is well established that the kidney is highly vulnerable to the damage induced by ROS due to its high content of polyunsaturated fatty acids (Rodrigo & Rivera [@CIT0064]). In the present study, penconazole induced lipid peroxidation in the kidney of adult rats as revealed by a marked elevation in MDA. Previous findings of Sakr ([@CIT0067]) have shown that treatment with mancozeb, another fungicide, induces a significant increase in lipid peroxidation in albino rats. The increased MDA level observed in tissues of animals exposed to penconazole could be probably ascribed to the excessive production of ROS caused by this fungicide leading to renal injury. In fact, the generation of the H~2~O~2~ was enhanced following treatment of rats with penconazole. Consistent with these observations, Poovala et al. ([@CIT0059]) have found an increase of H~2~O~2~ levels following exposure of renal tubular cells to acephate, an organophosphate insecticide. H~2~O~2~ generation has been involved in the pathogenesis of several forms of acute tubular injury, where the lipid peroxidation process plays an essential role (Salahudeen [@CIT0068]). Mitochondria are considered to be the major cellular source for H~2~O~2~ production. Hence, it is suggested that penconazole, with lipophilic nature, could easily cross the cytoplasmic membrane to reach mitochondria, causing thereby the dysfunction of the mitochondrial respiratory chain and an enhanced generation of ROS including H~2~O~2~ which could be converted to a reactive hydroxyl radical. The latter can trigger a lipid peroxidation chain reaction by extracting an allylic hydrogen from polyunsaturated fatty acids.

As a consequence of lipid peroxidation, biological membranes are affected leading to the loss of their fluidity, a modification of their potential or an increase of their permeability leading to a cellular damage. In this regard, LDH, an intracellular enzyme, is recognized to be a potent marker for assessing chemical's toxicity. This enzyme is released into the blood stream once the cell membrane integrity is disrupted in the conditions of oxidative stress (Zou et al. [@CIT0086]). Our results demonstrated that, in penconazole-treated rats, LDH activity decreased significantly in kidney tissues while it increased in plasma when compared to controls. This observation might be attributed to a generalized increase in membrane permeability as a result of lipid peroxidation under ROS generation by penconazole.

In addition to LDH, ALP and GGT, which are membrane bound enzymes, can be also used as the reliable biomarkers of cell and tissue damage induced by toxic substances. In the current study, penconazole exposure resulted in a significant decline of plasma ALP activity which might be attributed to a decreased osteoblastic activity in bone, since ALP is formed in the osteoblasts. Hence, the bone tissue could be affected by penconazole exposure. Our results showed also a significant reduction in plasma GGT activity in penconazole-treated rats which might be due to the occurrence of oxidative stress through an excessive generation of ROS, as reported by Abdelhalim and Moussa ([@CIT0001]) in rats exposed to gamma radiation. Likewise, Abd-Alrahman et al. ([@CIT0002]) have demonstrated that exposure of rats to difenoconazole, another triazole fungicide, decreases plasma GGT activity.

Moreover, ROS can also directly attack cellular proteins leading to a severe failure of their biological functions and even cell death. Among the various oxidative modifications of amino acids in proteins, PCO formation may be an early marker for protein oxidation. Indeed, the process of protein carbonylation is nonreversible, causing conformational changes, decreases enzyme catalytic activities, resulting in the breakdown of proteins by proteases (Zhang et al. [@CIT0085]). In addition, the degree of protein damage in experimental rats can be estimated by a novel marker, AOPP. Under our experimental conditions, the increased PCO and AOPP levels were detected in the kidney of penconazole-treated rats suggesting that oxidative protein damage might be one of the mechanisms underlying penconazole-induced nephrotoxicity. Previous studies have shown that pesticides exposure may promote protein oxidation in the kidney of adult rats (Ben Amara et al. [@CIT0013]).

Treatment with *N. retusa* aqueous extract prevented oxidative damage induced by penconazole in the renal tissue, objectified by a significant decrease in the levels of MDA, H~2~O~2~, PCO and AOPP, as well as an improvement of ALP and GGT activities. This might be attributed to the free radical scavenging property of the plant extract.

Defence of renal cells against oxidative stress is maintained by several mechanisms including enzymatic and non-enzymatic antioxidants. Antioxidant enzymes such as CAT, SOD and GPx present an impressive array of defence mechanisms, since they are effective in maintaining ROS under adequate concentrations. SOD accomplishes its antioxidant function by catalyzing the dismutation of the superoxide radical ($O_{2}^{\bullet -}$) to H~2~O~2~, protecting thereby the kidney from $O_{2}^{\bullet -}$ damage. The production of the potentially harmful H~2~O~2~ is counteracted by the action of CAT and GPx, catalyzing the decomposition of this ROS to water and oxygen. In the current study, penconazole treatment provoked changes in renal enzymatic antioxidant systems as confirmed by the increased activities of CAT, SOD and GPx. The increment in the activities of these enzymes might be understood as an adaptive response of the body to oxidative stress as reported by Sengupta et al. ([@CIT0069]) in rats exposed to chromium.

As antioxidant enzymes work in synergy with non-enzymatic antioxidants, it was necessary to evaluate renal GSH and NPSH levels. GSH is thought to be an important endogenous defence molecule against peroxidative destruction of cellular membranes. This tripeptide can react directly with ROS and electrophilic metabolites and protects essential thiol groups from oxidation. In our study, significant rises in kidney GSH and NPSH levels were noted following penconazole treatment, which might occur as a mechanism of protection against oxidative damage.

Cellular defence against oxidative stress is also induced by metallothionein (MT), a small metal-binding and cysteine-rich protein. Its high thiol content makes it a powerful OH^•^ scavenger more efficient than GSH (Deneke [@CIT0022]). This protein has been widely used to identify specific responses to heavy metals pollution. MT synthesis can be also induced by compounds other than heavy metals leading to ROS production. In our study, penconazole stimulated the kidney to produce MT as illustrated by its significant increase when compared to controls. This could be considered as a defence mechanism, in addition to the antioxidants, against oxidative stress and the adverse effects induced by this fungicide.

Interestingly, treatment with *N. retusa* aqueous extract improved the enzymatic and non-enzymatic antioxidant status of rats exposed to penconazole, indicating that this plant extract participated in the reduction of penconazole toxicity by decreasing oxidative stress due to the ability of its antioxidant compounds to scavenge free radicals.

It is worth mentioning that, in a previous study, we have shown that the aqueous extract of *N. retusa* fruit exhibited a significant protective effect against penconazole-induced oxidative stress in the liver of adult rats (Chaâbane et al. [@CIT0018]). Based on our previous and present findings, penconazole toxicity in rats seems to be more pronounced in the liver than in the kidney. Indeed, penconazole treatment increased the hepatic levels of MDA, H~2~O~2,~ AOPP, NPSH, MT, SOD, CAT and GPx by 103, 56, 181, 23, 17, 36, 52 and 52%, respectively. In line with this, tests on short-term toxicity have shown that the liver is the main target organ for this fungicide (EFSA [@CIT0027]). As for the beneficial effect of *N. retusa* extract administration on penconazole toxicity, this plant extract showed to be more effective in reducing the elevation of MDA (−41%), H~2~O~2~ (−14%), AOPP (−44%), NPSH (−10%) and CAT (−22%) levels caused by penconazole in the liver of adult rats than in the renal tissue. While, it was found to be less successful in decreasing the rise of MT (−8%), SOD (−9%) and GPx (−13%) levels induced by penconazole in the hepatic tissue as compared to the present findings. So, the hepatoprotective potential of *N. retusa* extract appears to be more potent than its nephroprotective activity, especially in regards to its modulatory effects on lipid and protein oxidation.

The biochemical findings obtained in the current work were substantiated with histopathological observations. The renal tubules as well as the glomeruli were affected after penconazole treatment. In fact, kidney sections of penconazole-treated rats showed a renal tubular damage characterized by necrosis of the epithelial cells lining the tubules. This fungicide caused also an infiltration of leucocytes. These observations could be due to the accumulation of free radicals as a consequence of a lipid peroxidation increase in the renal tissue of penconazole-treated rats. Similar histopathological observations have been reported in kidney of rats treated with the metiram, another fungicide (Sakr et al. [@CIT0066]). Moreover, kidney of rats exposed to penconazole showed glomeruli fragmentation and an enlarged Bowman's space which matched with the previous findings of Shah and Iqbal ([@CIT0070]) in diazinon-treated rats.

Kidney histoarchitecture impairment, induced by penconazole, was remarkably reduced by the aqueous extract of *N. retusa* fruit confirming, consequently, the biochemical results.

Polyphenol constituents of *N. retusa* fruit aqueous extract might participate with their antioxidant activities in nephroprotection. In fact, the analysis of this extract by HPLC-HRMS is the first study which identified the phenolic compounds, including phenolic acids and flavonoids, whose major components were (3′-*O*-methyl-(-)-epicatechin 7-*O*-glucuronide, 4′-*O*-methyl-(-)-epicatechin 3′-*O*-glucuronide, epicatechin 3′-*O*-glucuronide, p-coumaric acid, cyanidin 3-*O*-rutinoside, 3-*O*-methylgallic acid, taxifoline and kaempferol 3-glucoside). They have been reported for their powerful antioxidant activity (Natsume et al. [@CIT0050]; Luceri et al. [@CIT0047]; Mulabagal et al. [@CIT0049]; Gargouri et al. [@CIT0033]; Topal et al. [@CIT0074]; Wang et al. [@CIT0077]). Furthermore, the nephroprotective effect of chlorogenic acid against cisplatin-induced kidney injury has been previously reported by Domitrović et al. ([@CIT0024]). In addition, Vijayaprakasha et al. ([@CIT0076]) have shown that kaempferol alleviates the toxicity induced by mercuric chloride in the kidney of rats. According to Zadernowski et al. ([@CIT0083]), hydroxycaffeic acid has been found to be the major phenolic acid in blackberries but information regarding its biological activities seems to be lacking. In general, polyphenols have been shown to attenuate renal dysfunction, to decrease lipid peroxidation and ROS, and to improve renal histoarchitecture (Wongmekiat et al. [@CIT0078]). The renoprotective effect of phenolic compounds is thought to be essentially due to their wide range of biological actions, such as free radical scavenging, metal chelation and enzyme modulation capacities (Pietta et al. [@CIT0057]). In particular, flavonoids represent an important class of phenolic compounds and have been reported to inhibit xenobiotic-induced nephrotoxicity in animal models (Devipriya & Shyamaladevim [@CIT0023]). They exhibit a potent antioxidant effect, which is attributed to their free radical scavenging properties, their ability to reduce free radicals formation (Pietta [@CIT0058]) and to stabilize membranes by decreasing their fluidity (Arora et al. [@CIT0007]), which may inhibit the lipid peroxidation process. Furthermore, the mineral composition of *N. retusa* fruit could contribute to its antioxidant property. Trace elements such as Fe^2+^, Zn^2+ ^and Cu^2+ ^have been reported to play the key roles as cofactors for endogenous antioxidant enzymes (Powell [@CIT0061]; Michalak [@CIT0048]). The biological activities of these microelements are related to the presence of unpaired electrons allowing their participation in redox reactions.

Overall, our results suggested that the main mechanism underlying penconazole nephrotoxicity in rats involve the generation of ROS, resulting in the subsequent formation of oxidative stress in the renal tissue. According to the literature data, increased production of ROS can activate redox sensitive transcription factors, such as nuclear factor-κB (NF-κB), and signal transduction pathways, like mitogen-activated protein kinases (MAPKs). These events may lead to tissue damage and dysfunction by promoting several disorders such as necrosis, apoptosis, inflammation and fibrosis. Indeed, NF-κB is a ubiquitous transcription factor governing the expression of genes encoding a series of proinflammatory cytokines and chemokines. Its activation plays, therefore, a pivotal role in the pathogenesis of inflammation, tissue injury and renal disease (An et al. [@CIT0006]). MAPKs represent a family of structurally related serine/threonine kinase enzymes, which include the extracellular-receptor kinases (ERK1/2), the c-Jun N-terminal kinases (JNK) and the p38 MAPKinases. The MAPKs pathway operates a crucial signalling pathway of cell death and inflammation in kidney (Xu et al. [@CIT0080]). In this context, it has been demonstrated, in animal models of diabetic nephropathy, that ROS mediate the activation of various signalling pathways induced by high glucose, including MAPKs and NF-κB, and up-regulate genes and proteins involved in glomerular mesangial expansion and tubule-interstitial fibrosis (Lee et al. [@CIT0044]). On the other hand, the nuclear factor erythroid-2-related factor (Nrf2), another transcription factor, is considered to be a main defence mechanism against oxidative stress in cells (Li et al. [@CIT0045]). Nrf2 expression and its nuclear translocation have been involved in the induction of antioxidant defences and phase II detoxifying enzymes (Xu et al. [@CIT0081]). In an experimental model of acute kidney injury in mice, Sahu et al. ([@CIT0065]) found that baicalein, a bioflavonoid, prevents cisplatin-induced renal injury by up-regulating Nrf2 expression and down-regulating the MAPKs and NF-κB pathways. Hence, to improve our understanding of the molecular mechanisms of penconazole-induced nephrotoxicity, it would be interesting to examine, in the future studies, the target pathways activated by ROS in renal cells exposed to this fungicide and the protective effects of *N. retusa* fruit extract.

Conclusions {#s0039}
===========

Our study provided a new knowledge regarding the phenolic composition of *N. retusa* fruit aqueous extract which showed to be a source of phenolic acids and flavonoids. Moreover, we demonstrated the beneficial contribution of this extract in mitigating penconazole-induced nephrotoxicity in adult rats. Therefore, *N. retusa* fruit aqueous extract could be used as a potential food supplement for the treatment of penconazole-induced kidney injury.
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